A U.S. study found that a protein called Lefty, secreted only in human embryonic stem cells, can curb the growth and spread of melanomas and aggressive breast cancers. The tumor-suppressive capabilities of the human embryonic stem cell microenvironment "provide previously unexplored novel therapeutic modalities for cancer treatment," the study's lead researcher said.

Full Story:

Related Summaries